Fortis Life Sciences

Executive Summary

Fortis Life Sciences (founded 2021, Waltham, MA) is a private integrated provider of critical reagents, components, and contract services for research, diagnostic, and therapeutic applications. The company differentiates itself through in-house design, validation, and manufacturing of scalable, fit-for-purpose solutions, targeting high-growth areas such as antibodies, diagnostics, and drug delivery. With a focus on quality and speed, Fortis aims to serve the growing demand for custom biologics and assay components from biopharma and diagnostic developers. Despite being early-stage, the company's asset-light model and emphasis on partnerships position it to capture market share in the fragmented life science tools space. Key risks include competition from established players and reliance on few large contracts.

Upcoming Catalysts (preview)

• TBDAnnouncement of strategic partnership or supply agreement with a top-20 biopharma40% success
• TBDExpansion of manufacturing capacity or new facility opening50% success
• TBDSeries A or B funding round to accelerate commercial growth30% success